Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Sagitta Biotech is 0.7% (low). The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
3 mandates
2
active directors
ALLAER DidierDirectorNOSHAQ PARTNERSDirector+1 in history
All directors & mandates Publicationslatest 23-04-2026
15
publications in the State GazetteCapital decrease of €750,000 to €1,020,000All publications & acts Network & structure
2
connected companiesSee network & structure
Connections
2 connected companiesParent · 61 subsidiaries · 1 location
Control→
Trust signals
3 signalsMore than 3 years active
Founded in 2019 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.7%
Low
0%0,5%1,5%4%10%≥25%
Young company
+Lower-failure-rate sector
−Lower-risk legal form
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110
Primary activity highlighted.
Names & trade names
| Legal nameFR | Sagitta Biotech |
Registered office
Avenue Hippocrate 5 bus GIGA
4000 Liège, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.